Jaguar Health Inc (JAGX)

[ShadowDiviner72]

I am not going to fall in love . After phase 3 I will be out for some time. But market capacity will always reflect a part of the future. The future is Mytesi for CID SBS and MVIS , sales for MVIS and SBS will start in 2025 under early patient acces program in Europe. FDA approval for CID (if positive P3) will come in 2025 as well. Canalevia in the meantime, approved for general diarrhea in dogs (+16 million dogs go to the vet for diarrhea / year , in the US and EU alone) ...

Market cap WILL reflect this partly, and than 50 million is a big joke.

Float is TINY, any good news (phase 3) will send this right back up.

BTW, data postponed ? they were clear, you guys just can't read press releases. LISA made a big mistake in november, by thinking she would get the results of PART 1. (impossible, they never unblind a double blinded study for a data readout). PART 2 was finished in november, results would definitely be in 2024.

Second, she told us they faced a statistical error (not so difficult if you collect data from 6 different countries with several investigators).

They hired a biostatistic expert, that previously worked with crofelemer, to solve this problem (hence forthcoming in the PR's). Now, she upgraded to 'imminent'. To me that says, Error is solved, data is ready.